260 related articles for article (PubMed ID: 35662004)
1. Treatment approach to connective tissue disease-associated interstitial lung disease.
Wilson TM; Solomon JJ; Demoruelle MK
Curr Opin Pharmacol; 2022 Aug; 65():102245. PubMed ID: 35662004
[TBL] [Abstract][Full Text] [Related]
2. The potential utility of anterior upper lobe honeycomb-like lesion in interstitial lung disease associated with connective tissue disease.
Yamakawa H; Ogura T; Sato S; Nishizawa T; Kawabe R; Oba T; Kato A; Horikoshi M; Akasaka K; Amano M; Kuwano K; Sasaki H; Baba T; Matsushima H
Respir Med; 2020 Oct; 172():106125. PubMed ID: 32911135
[TBL] [Abstract][Full Text] [Related]
3. Connective tissue disease-associated interstitial lung disease.
Storrer KM; Müller CS; Pessoa MCA; Pereira CAC
J Bras Pneumol; 2024; 50(1):e20230132. PubMed ID: 38536980
[TBL] [Abstract][Full Text] [Related]
4. Learnings from clinical trials in patients with connective tissue disease-associated interstitial lung disease.
Higuero Sevilla JP; Memon A; Hinchcliff M
Arthritis Res Ther; 2023 Jul; 25(1):118. PubMed ID: 37422652
[TBL] [Abstract][Full Text] [Related]
5. Connective tissue disease-related interstitial lung disease.
Demoruelle MK; Mittoo S; Solomon JJ
Best Pract Res Clin Rheumatol; 2016 Feb; 30(1):39-52. PubMed ID: 27421215
[TBL] [Abstract][Full Text] [Related]
6. Cyclophosphamide for connective tissue disease-associated interstitial lung disease.
Barnes H; Holland AE; Westall GP; Goh NS; Glaspole IN
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD010908. PubMed ID: 29297205
[TBL] [Abstract][Full Text] [Related]
7. Review series: Aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ?
de Lauretis A; Veeraraghavan S; Renzoni E
Chron Respir Dis; 2011; 8(1):53-82. PubMed ID: 21339375
[TBL] [Abstract][Full Text] [Related]
8. Clinical Presentation of Connective Tissue Disease Patients with and without Interstitial Lung Disease: A Retrospective Study.
Sambataro G; Libra A; Spicuzza L; Palmucci S; Conti P; Spagnolo E; Colaci M; Malatino L; Orlandi M; Sambataro D; Vancheri C
Respiration; 2023; 102(6):405-415. PubMed ID: 37231870
[TBL] [Abstract][Full Text] [Related]
9. Prevalence, imaging patterns and risk factors of interstitial lung disease in connective tissue disease: a systematic review and meta-analysis.
Joy GM; Arbiv OA; Wong CK; Lok SD; Adderley NA; Dobosz KM; Johannson KA; Ryerson CJ
Eur Respir Rev; 2023 Mar; 32(167):. PubMed ID: 36889782
[TBL] [Abstract][Full Text] [Related]
10. Novel Therapeutic Approaches in Connective Tissue Disease-Associated Interstitial Lung Disease.
Mulcaire-Jones E; Pugashetti JV; Oldham JM; Khanna D
Semin Respir Crit Care Med; 2024 Jun; 45(3):435-448. PubMed ID: 38740369
[TBL] [Abstract][Full Text] [Related]
11. Connective Tissue Disease-Associated Interstitial Lung Disease: A Focused Review.
Solomon JJ; Fischer A
J Intensive Care Med; 2015 Oct; 30(7):392-400. PubMed ID: 24371251
[TBL] [Abstract][Full Text] [Related]
12. Treatment of pulmonary hypertension in patients with connective tissue disease and interstitial lung disease.
Mittoo S; Jacob T; Craig A; Bshouty Z
Can Respir J; 2010; 17(6):282-6. PubMed ID: 21165350
[TBL] [Abstract][Full Text] [Related]
13. Management of connective tissue diseases associated interstitial lung disease: a review of the published literature.
Wallace B; Vummidi D; Khanna D
Curr Opin Rheumatol; 2016 May; 28(3):236-45. PubMed ID: 27027811
[TBL] [Abstract][Full Text] [Related]
14. Rituximab versus cyclophosphamide for the treatment of connective tissue disease-associated interstitial lung disease (RECITAL): study protocol for a randomised controlled trial.
Saunders P; Tsipouri V; Keir GJ; Ashby D; Flather MD; Parfrey H; Babalis D; Renzoni EA; Denton CP; Wells AU; Maher TM
Trials; 2017 Jun; 18(1):275. PubMed ID: 28619061
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and treatment of connective tissue disease-associated interstitial lung disease.
Vij R; Strek ME
Chest; 2013 Mar; 143(3):814-824. PubMed ID: 23460159
[TBL] [Abstract][Full Text] [Related]
16. Mean pulmonary arterial pressure as a prognostic indicator in connective tissue disease associated with interstitial lung disease: a retrospective cohort study.
Takahashi K; Taniguchi H; Ando M; Sakamoto K; Kondoh Y; Watanabe N; Kimura T; Kataoka K; Suzuki A; Ito S; Hasegawa Y
BMC Pulm Med; 2016 Apr; 16(1):55. PubMed ID: 27094018
[TBL] [Abstract][Full Text] [Related]
17. The Role of Macrophages in Connective Tissue Disease-Associated Interstitial Lung Disease: Focusing on Molecular Mechanisms and Potential Treatment Strategies.
Tseng CC; Sung YW; Chen KY; Wang PY; Yen CY; Sung WY; Wu CC; Ou TT; Tsai WC; Liao WT; Chen CJ; Lee SC; Chang SJ; Yen JH
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569370
[TBL] [Abstract][Full Text] [Related]
18. Connective Tissue Disease-Associated Interstitial Lung Diseases: Unresolved Issues.
Aparicio IJ; Lee JS
Semin Respir Crit Care Med; 2016 Jun; 37(3):468-76. PubMed ID: 27231868
[TBL] [Abstract][Full Text] [Related]
19. Treatment of connective tissue disease-associated interstitial lung disease: the pulmonologist's point of view.
Koo SM; Uh ST
Korean J Intern Med; 2017 Jul; 32(4):600-610. PubMed ID: 28704913
[TBL] [Abstract][Full Text] [Related]
20. Targeting CD20 in the treatment of interstitial lung diseases related to connective tissue diseases: A systematic review.
Bellan M; Patrucco F; Barone-Adesi F; Gavelli F; Castello LM; Nerviani A; Andreoli L; Cavagna L; Pirisi M; Sainaghi PP
Autoimmun Rev; 2020 Feb; 19(2):102453. PubMed ID: 31838163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
